Navigation Links
Karen Beemon wins the 2007 Retrovirology Prize
Date:12/10/2007

It was announced today that Dr Karen Beemon has been awarded the third annual Retrovirology Prize. Dr Beemon will receive a $3000 cheque and a crystal trophy and is interviewed in an article published today in the open access journal Retrovirology. She is Professor and Chair of the Biology Department, Johns Hopkins University.

I am very honored to receive the 2007 Retrovirology Prize. It is wonderful to be recognized by the Retrovirology community. It is gratifying that this prize was awarded for basic research with chicken retroviruses. I became fascinated with these viruses as a graduate student and have studied them ever since. I am amazed at how complex and elegant the simple retroviruses actually are and how much they have taught us about viral gene expression and mechanisms of oncogenesis. I am indebted to my mentors, students, and collaborators, who contributed to this research.

The Retrovirology Prize, awarded annually, recognises an outstanding mid-career retrovirologist aged 45 to 60. The prize, supported by the Ming K. Jeang Foundation, alternates between HIV and non-HIV research. Last years winner was Dr Joe Sodroski, Professor of Pathology at the Dana-Farber Cancer Institute, Harvard Medical School and Professor of Immunology and Infectious Diseases at Harvard School of Public Health.

The M Jeang Retrovirology Prize winner is selected, by Retrovirologys Editors, from nominations submitted by the journals Editorial Board. Representing the Editors of Retrovirology, Kuan-Teh Jeang explained why they awarded Dr Beemon with the Retrovirology prize. Professor Beemon has made tremendous contributions to our understanding of how retroviruses transform cells. She was instrumental in establishing that one of the important transformation mechanisms is the aberrant phosphorylation of cellular proteins on tyrosine residues.

Dr Beemon received her PhD in 1974 from the University of California. She was a postdoctoral fellow there and also at the Salk institute. She was among the first to develop and apply molecular techniques to characterise the genomes of RNA viruses, describe recombination between viral genomes, characterise sarcoma-specific sequences, and perform structure-function analysis of src proteins. Of particular importance, was her discovery that transformation mechanisms of multiple classes of retroviruses involve aberrant phosphorylation of cellular proteins at tyrosine residues. Over the last two decades, Dr. Beemon has contributed significantly to the scientific communitys understanding of the role of cis-acting regulatory elements in regulation of RNA splicing, polyadenylation, nuclear export and nonsense-mediated RNA decay.

Dr. Beemons honors in research recognition include the Faculty Research Award from the American Cancer Society and the Fogarty Senior International Fellowship. She has published nearly 80 peer-reviewed manuscripts and review articles in journals ranked in the top of their subject field (e.g. Cell, PNAS, Journal of Virology, Molecular Cellular Biology, Oncogene, RNA). This year she was appointed a senior editor of the Journal of Virology.


'/>"/>

Contact: Charlotte Webber
press@biomedcentral.com
44-020-763-19980
BioMed Central
Source:Eurekalert

Related biology news :

1. ETH Zurich professor Ari Helenius awarded Benoist Prize
2. Columbia to award 2007 Horwitz Prize to three generations of teacher-student scientists
3. Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine
4. Professor Sir Martin Evans wins Nobel Prize for Medicine
5. Gregory Hannon wins 2007 Paul Marks Prize for contributions to understanding and treating cancer
6. Nobel Peace Prize 2007 to intergovernmental panel on climate change
7. NARSAD presents 2007 prizes for outstanding achievement in neuroscience and psychiatric research
8. Neilson member of Nobel Prize-winning panel of scientists
9. Maynard Olson receives $500,000 Gruber Genetics Prize
10. Shigetada Nakanishi receives $500,000 Gruber Neuroscience Prize
11. 2007 Albert Maucher Prize for Outstanding Young Geoscientists
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)...  VoiceIt is excited to announce its new ... By working together, VoiceIt and VoicePass will offer ... take slightly different approaches to voice biometrics, collaboration ... usability. Both ... "This marketing and technology partnership allows ...
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
(Date:5/3/2016)... VILNIUS, Lithuania , May 3, 2016 /PRNewswire/ ... today released the MegaMatcher Automated Biometric Identification ... deployment of large-scale multi-biometric projects. MegaMatcher ABIS can ... and accuracy using any combination of fingerprint, face ... of MegaMatcher SDK and MegaMatcher ...
Breaking Biology News(10 mins):
(Date:5/20/2016)... ... ... Kablooe Design, a leading provider of product design and development services to medical ... “We have worked hard to build long-term relationships,” says President and CEO, Tom KraMer. ... serving their product design and development needs through the years.” , Kablooe has earned ...
(Date:5/20/2016)... ... May 20, 2016 , ... The recent recall by ... reported by Food Safety News on May 12, 2016(1), demonstrates the need for faster ... CEO of Baltimore-based biotech firm, PathSensors, Inc. , PathSensor’s latest solution ...
(Date:5/19/2016)... RIDGE, British Columbia , May 19, 2016 ... AdvanTec Global Innovations Inc. (AGI), based out of ... recently added Greenlane Biogas Ltd. to its existing ... 2-year contract manufacturing agreement. AFS along with its ... Technologies (ABT) is a vertically integrated industrial group ...
(Date:5/19/2016)... ... May 19, 2016 , ... KCAS ... welcomed Abu Siddiqui as Director, Large Molecule & Biomarker Bioanalysis. , Dr. Siddiqui ... translational biomarker discovery studies for preclinical and clinical safety programs. “We’ve seen significant ...
Breaking Biology Technology: